Analyst Ratings For NASDAQ:IPXL – Impax Laboratories (NASDAQ:IPXL)
Today, Barclays initiated coverage on NASDAQ:IPXL – Impax Laboratories (NASDAQ:IPXL) with a Overweight with a price target of $27.00.
Some recent analyst ratings include
- 5/1/2018-Barclays initiated coverage with a Overweight rating.
- 3/7/2018-SunTrust Banks initiated coverage with a Buy rating.
Recent Insider Trading Activity For NASDAQ:IPXL – Impax Laboratories (NASDAQ:IPXL)
NASDAQ:IPXL – Impax Laboratories (NASDAQ:IPXL) has insider ownership of 3.20% and institutional ownership of 90.41%.
- On 5/31/2017 Michael Nestor, Insider, sold 1,130 with an average share price of $15.00 per share and the total transaction amounting to $16,950.00.
- On 5/17/2017 Michael Nestor, Insider, sold 857 with an average share price of $16.48 per share and the total transaction amounting to $14,123.36.
- On 5/12/2017 Michael Nestor, Insider, sold 700 with an average share price of $17.11 per share and the total transaction amounting to $11,977.00.
- On 8/15/2016 Leslie Z Benet, Director, sold 10,092 with an average share price of $22.81 per share and the total transaction amounting to $230,198.52.
- On 9/11/2015 Mark A Schlossberg, SVP, sold 7,457 with an average share price of $43.30 per share and the total transaction amounting to $322,888.10.
- On 9/10/2015 Michael Nestor, Insider, sold 5,000 with an average share price of $43.56 per share and the total transaction amounting to $217,800.00.
- On 8/31/2015 Michael Markbreiter, Director, sold 28,000 with an average share price of $41.70 per share and the total transaction amounting to $1,167,600.00.
Recent Trading Activity for NASDAQ:IPXL – Impax Laboratories (NASDAQ:IPXL)
Shares of NASDAQ:IPXL – Impax Laboratories closed the previous trading session at 18.82 up +0.03 0.13% with 66047 shares trading hands.